Smyth, E. C., Vlachogiannis, G., Hedayat, S., Harbery, A., Hulkki-Wilson, S., Salati, M., . . . Valeri, N. (2021). EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers. Gut, 70(9), . https://doi.org/10.1136/gutjnl-2020-322658
Chicago-Zitierstil (17. Ausg.)Smyth, Elizabeth C., et al. "EGFR Amplification and Outcome in a Randomised Phase III Trial of Chemotherapy Alone or Chemotherapy Plus Panitumumab for Advanced Gastro-oesophageal Cancers." Gut 70, no. 9 (2021). https://doi.org/10.1136/gutjnl-2020-322658.
MLA-Zitierstil (9. Ausg.)Smyth, Elizabeth C., et al. "EGFR Amplification and Outcome in a Randomised Phase III Trial of Chemotherapy Alone or Chemotherapy Plus Panitumumab for Advanced Gastro-oesophageal Cancers." Gut, vol. 70, no. 9, 2021, https://doi.org/10.1136/gutjnl-2020-322658.